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background:  Cardiac resynchronization therapy (CRT) confers mortality benefit in cardiomyopathy patients with underlying electrical dyssynchrony 
and has since become the mainstay of treatment. Nearly 25% of these patients are known to have underlying atrial fibrillation which can pose a 
challenge in delivering effective bi-ventricular pacing. Given that the randomized controlled trials that demonstrate the efficacy of CRT excluded 
patients with atrial fibrillation, the benefit in this cohort needs further scrutiny.
methods:  We searched PubMed, Cochrane Database of Systematic Reviews and Google scholar using the search terms “atrial fibrillation” and 
“cardiac resynchronization therapy.” Included studies compared the clinical outcome of patients in sinus rhythm (SR) versus atrial fibrillation (AF). 
Random effects meta-analysis was performed to pool data.
results:  Our search terms identified more than 45000 articles. A total of 10 papers met the inclusion criteria and were included in the present 
analysis. Comparison of mortality between the two groups are shown in the figure.
Other outcomes analysed were improvement in functional capacity (as measured by 6-minute walk distance) and improvement in EF. Although the 
benefit was noted in both groups, patients in SR experienced a greater benefit.
conclusions:  Our data suggests that patients in SR experienced a greater degree of mortality benefit compared to those in AF, despite a notable 
improvement in symptoms seen in both groups.
